Serum Chemerin Levels in relation to Osteoporosis and Bone Mineral Density: A Case-Control Study

Table 3

Bivariate correlation analyses between bone mineral density with serum chemerin levels and anthropometric and laboratory variables.

	Osteoporosis group								Control group
	FBMD				LBMD				FBMD				LBDM
	Unadjusted		Adjusted		Unadjusted		Adjusted		Unadjusted		Adjusted		Unadjusted		Adjusted
	value	value	value	value	value	value	value	value	value	value	R value	value	R value	value	value	value
Age		<0.01	NA	NA		<0.01	NA	NA		0.035	NA	NA		<0.01	NA	NA
BMI		0.822	NA	NA		0.626	NA	NA		0.963	NA	NA		0.848	NA	NA
Chemerin		<0.01		<0.01		<0.01		0.172		<0.01		<0.01		<0.01		<0.01
TC		0.303		0.901		0.262		0.365		0.217		0.243		0.685		0.451
TG		0.655		0.056		0.310		0.038		0.203		0.071		0.804		0.191
HDL-C		0.039		<0.01		0.833		0.212		0.013		0.029		0.151		0.491
LDL-C		0.976		0.504		0.229		0.945		0.169		0.175		0.733		0.762
AKP		0.082		0.101		0.171		0.047		0.056		0.048		0.111		0.049
FBG		<0.01		<0.01		0.030		<0.01		0.187		0.075		0.220		0.029
Insulin		<0.01		<0.01		0.019		<0.01		0.234		0.359		0.135		0.346

Partial correlation analyses were performed to adjust age and BMI.
FBMD: femoral bone mineral density; LBMD: lumbar bone mineral density; BMI: body mass index; TC: total cholesterol; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; AKP: alkaline phosphatase; FBG: fasting blood glucose; NA: not applicable.